Concurrent Immunotherapy With Postoperative Radiotherapy in Intermediate/High Risk HNSCC Patients Unfit for Cisplatin: The IMPORT Study (IMPORT)

NCT04523883 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
316
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Collaborators